Brief: TCG Crossover GP II Reports 9.4% Passive Stake In Fulcrum Therapeutics As Of Sept 12 - SEC Filing
20/09/2024 21:25
Sept 20 (Reuters) - Fulcrum Therapeutics Inc FULC.O :
* TCG CROSSOVER GP II, LLC REPORTS 9.4% PASSIVE STAKE IN
FULCRUM
THERAPEUTICS AS OF SEPT 12 - SEC FILING
Source text for Eikon: ID:n0001193125-24-222915
Further company coverage: FULC.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Fulcrum Therapeutics
See all newsFulcrum down after announcing restructuring, plans to cut 85% jobs
Brief: Fulcrum Therapeutics Approves Restructuring Plan After Discontinuing Pociredir For Sickle Cell Disease
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Fulcrum
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Philip Morris
Fulcrum falls after discontinuing sickle cell drug program